1
23andMe Granted FDA Authorization for Genetic Test on Cancer Risk
23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk
Press releases from 23andMe Research Institute.
Visit mediacenter.23andme.com → On Hacker News Mar 2018 – Feb 2021
23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk
23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics January 15, 2021 Medscape study in collaboration with 23andMe finds Primary Care Physicians are increasingly more comfortable with…